SEPS
Desconocido
COLOTAN: Boosting advanced doctoral training in innovative colon targeting drugs
SEPS PHARMA
participó en un
H2020
H2020-MSCA-ITN-2020
The Colon Targeting Network (COLOTAN) is a European Training Network that will train 13 Early Stage Researchers (ESRs) in (bio)pharmaceutica...
2020-08-19 - 2024-12-31 | Financiado
2020-08-19 - 2024-12-31 | Financiado
NEW DEAL: New siRNA Nanotherapy for Inflammatory Bowel Diseases targeting Janus kinases
SEPS PHARMA
participó en un
H2020
H2020-NMBP-2016-2017
Inflammatory bowel diseases (IBD) are the second most common immune-mediated disorders in Europe, affecting more particularly young people....
2016-11-09 - 2021-09-30 | Financiado
2016-11-09 - 2021-09-30 | Financiado
* No se disponen de datos de la empresa actual.